Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | multidrug resistance associated protein 1 | 0.016 | 0.1004 | 0.1004 |
Leishmania major | ATP-binding cassette protein subfamily C, member 1, putative | 0.016 | 0.1004 | 0.5 |
Trypanosoma brucei | multidrug resistance protein E | 0.016 | 0.1004 | 0.5 |
Leishmania major | ABC-thiol transporter | 0.016 | 0.1004 | 0.5 |
Echinococcus multilocularis | glycogen phosphorylase | 0.0492 | 1 | 1 |
Giardia lamblia | Multidrug resistance-associated protein 1 | 0.016 | 0.1004 | 0.0039 |
Trichomonas vaginalis | glycogen phosphorylase, putative | 0.0492 | 1 | 0.5 |
Echinococcus multilocularis | multidrug resistance associated protein 7 | 0.016 | 0.1004 | 0.1004 |
Trypanosoma brucei | multidrug resistance-associated protein, putative | 0.016 | 0.1004 | 0.5 |
Trypanosoma cruzi | multidrug resistance-associated protein, putative | 0.016 | 0.1004 | 1 |
Leishmania major | ATP-binding cassette protein subfamily C, member 6, putative | 0.016 | 0.1004 | 0.5 |
Chlamydia trachomatis | glycogen phosphorylase | 0.0492 | 1 | 0.5 |
Echinococcus granulosus | Glycosyl transferase family 35 | 0.0492 | 1 | 1 |
Echinococcus granulosus | multidrug resistance associated protein 1 | 0.016 | 0.1004 | 0.1004 |
Loa Loa (eye worm) | ABC transporter transmembrane region family protein | 0.016 | 0.1004 | 0.0973 |
Trypanosoma cruzi | multidrug resistance-associated protein, putative | 0.016 | 0.1004 | 1 |
Schistosoma mansoni | glycogen phosphorylase | 0.0213 | 0.2438 | 0.1594 |
Trypanosoma cruzi | multidrug resistance protein E, putative | 0.016 | 0.1004 | 1 |
Entamoeba histolytica | glycogen phosphorylase, putative | 0.0213 | 0.2438 | 0.1594 |
Trypanosoma brucei | multidrug resistance-associated protein, putative | 0.016 | 0.1004 | 0.5 |
Echinococcus multilocularis | glycogen phosphorylase | 0.0492 | 1 | 1 |
Giardia lamblia | ABC transporter, putative | 0.016 | 0.1004 | 0.0039 |
Entamoeba histolytica | glycogen phosphorylase, putative | 0.0213 | 0.2438 | 0.1594 |
Echinococcus granulosus | glycogen phosphorylase | 0.0492 | 1 | 1 |
Entamoeba histolytica | glycogen phosphorylase, putative | 0.0492 | 1 | 1 |
Loa Loa (eye worm) | glycogen phosphorylase | 0.0492 | 1 | 1 |
Schistosoma mansoni | glycogen phosphorylase | 0.0492 | 1 | 1 |
Toxoplasma gondii | ABC transporter transmembrane region domain-containing protein | 0.016 | 0.1004 | 0.5 |
Leishmania major | pentamidine resistance protein 1 | 0.016 | 0.1004 | 0.5 |
Echinococcus granulosus | multidrug resistance associated protein 7 | 0.016 | 0.1004 | 0.1004 |
Loa Loa (eye worm) | hypothetical protein | 0.016 | 0.1004 | 0.0973 |
Leishmania major | ATP-binding cassette protein subfamily C, member 5, putative | 0.016 | 0.1004 | 0.5 |
Leishmania major | p-glycoprotein e | 0.016 | 0.1004 | 0.5 |
Giardia lamblia | Glycogen phosphorylase | 0.0492 | 1 | 1 |
Entamoeba histolytica | glycogenphosphorylase, putative | 0.0213 | 0.2438 | 0.1594 |
Entamoeba histolytica | glycogen phosphorylase, putative | 0.0492 | 1 | 1 |
Echinococcus multilocularis | Glycosyl transferase, family 35 | 0.0492 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0159 | 0.0969 | 0.0938 |
Giardia lamblia | Multidrug resistance-associated protein 1 | 0.016 | 0.1004 | 0.0039 |
Mycobacterium ulcerans | glycogen phosphorylase GlgP | 0.0213 | 0.2438 | 0.5 |
Trypanosoma brucei | p-glycoprotein | 0.016 | 0.1004 | 0.5 |
Leishmania major | ATP-binding cassette protein subfamily C, member 2, putative | 0.016 | 0.1004 | 0.5 |
Giardia lamblia | MRP-like ABC transporter | 0.016 | 0.1004 | 0.0039 |
Trichomonas vaginalis | glycogen phosphorylase, putative | 0.0492 | 1 | 0.5 |
Schistosoma mansoni | glycogen phosphorylase | 0.0492 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.016 | 0.1004 | 0.0973 |
Onchocerca volvulus | Glycogen phosphorylase homolog | 0.0492 | 1 | 0.5 |
Mycobacterium tuberculosis | Probable glycogen phosphorylase GlgP | 0.0213 | 0.2438 | 0.5 |
Echinococcus granulosus | glycogen phosphorylase | 0.0492 | 1 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.